BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36803368)

  • 1. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
    Zou J; Zhou L; Le Y; Fang Z; Zhong M; Nie F; Wei X; Zhang X; Chen Z; Cai L; Wang H; Xiong J; Fang Z; Xiang X
    Cell Commun Signal; 2023 Feb; 21(1):38. PubMed ID: 36803368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway.
    Yao Y; Liu Z; Huang S; Huang C; Cao Y; Li L; Guo H; Liu F; Huang S; Liao Q; He X; Chen J; Li J; Xiang X; Xiong J; Deng J
    Cell Death Discov; 2022 Feb; 8(1):79. PubMed ID: 35210431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.
    Salah Z; Cohen S; Itzhaki E; Aqeilan RI
    Cell Cycle; 2013 Dec; 12(24):3817-23. PubMed ID: 24107629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.
    Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y
    Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881
    [No Abstract]   [Full Text] [Related]  

  • 5. WWP2 regulates proliferation of gastric cancer cells in a PTEN-dependent manner.
    Wang K; Liu J; Zhao X; Li H; Luo G; Yu Y; Guo Y; Zhang L; Zhu J; Wang S; Hua W; Yang A; Zhang R; Li J
    Biochem Biophys Res Commun; 2020 Jan; 521(3):652-659. PubMed ID: 31677789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
    Salah Z; Melino G; Aqeilan RI
    Cancer Res; 2011 Mar; 71(5):2010-20. PubMed ID: 21212414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
    Yeung B; Ho KC; Yang X
    PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression.
    Wang L; Lin M; Chu M; Liu Y; Ma J; He Y; Wang ZW
    EBioMedicine; 2020 Jun; 56():102795. PubMed ID: 32460168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
    Verma S; Yeddula N; Soda Y; Zhu Q; Pao G; Moresco J; Diedrich JK; Hong A; Plouffe S; Moroishi T; Guan KL; Verma IM
    Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7363-7370. PubMed ID: 30918126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 12. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
    Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
    Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.
    Zhang J; Liu H; Hou L; Wang G; Zhang R; Huang Y; Chen X; Zhu J
    Mol Cancer; 2017 Sep; 16(1):151. PubMed ID: 28893265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].
    Ho KC; Zhou Z; She YM; Chun A; Cyr TD; Yang X
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4870-5. PubMed ID: 21383157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation.
    Zhu W; He X; Hua Y; Li Q; Wang J; Gan X
    J Biol Chem; 2017 Jul; 292(27):11178-11188. PubMed ID: 28500134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of WWP2 aggravates Type 2 diabetes mellitus-induced vascular endothelial injury through modulating ubiquitination and degradation of DDX3X.
    You S; Xu J; Yin Z; Wu B; Wang P; Hao M; Cheng C; Liu M; Zhao Y; Jia P; Jiang H; Li D; Cao L; Zhang X; Zhang Y; Sun Y; Zhang N
    Cardiovasc Diabetol; 2023 May; 22(1):107. PubMed ID: 37149668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1.
    Ji J; Ding K; Luo T; Xu R; Zhang X; Huang B; Chen A; Zhang D; Miletic H; Bjerkvig R; Thorsen F; Wang J; Li X
    Oncogene; 2020 Jan; 39(5):1125-1139. PubMed ID: 31605013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.
    He Y; Zhou J; Wan Q
    Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling.
    Zhang J; Wang G; Chu SJ; Zhu JS; Zhang R; Lu WW; Xia LQ; Lu YM; Da W; Sun Q
    Oncotarget; 2016 Mar; 7(13):16180-93. PubMed ID: 26921249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
    Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.